Evidence map›Paper›PMID 33489464›Full record

ArticleAmerican journal of stem cells2020

HspB5 protects mouse neural stem/progenitor cells from paraquat toxicity.

Naveen Kumar Mekala, Shyama Sasikumar, Kranthi Kiran Akula, Yash Parekh, Ch Mohan Rao, Kiran Kumar Bokara

Open access · greenAbstract read
In one paragraph

Article in American journal of stem cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Naveen Kumar MekalaCollege of Medicine, Central Michigan University Mt Pleasant, MI 48858, USA.
Shyama SasikumarDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad Kandi-502285, Sangareddy, Telangana, India.
Kranthi Kiran AkulaCSIR-Centre for Cellular and Molecular Biology, Annexe-II, Medical Biotechnology Complex Uppal Road, Hyderabad, Telangana 500007, India.
Yash ParekhCSIR-Centre for Cellular and Molecular Biology, Annexe-II, Medical Biotechnology Complex Uppal Road, Hyderabad, Telangana 500007, India.
Ch Mohan RaoCSIR-Centre for Cellular and Molecular Biology, Annexe-II, Medical Biotechnology Complex Uppal Road, Hyderabad, Telangana 500007, India.
Kiran Kumar BokaraCSIR-Centre for Cellular and Molecular Biology, Annexe-II, Medical Biotechnology Complex Uppal Road, Hyderabad, Telangana 500007, India.
Centre for Cellular and Molecular Biology · INCentral Michigan University · USIndian Institute of Technology Hyderabad · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHspB5 (αB-crystallin) is known to be involved in a variety of cellular functions, including, protection of cells from oxidative damage and inhibiting apoptosis. Neural stem/progenitor cells (NSPCs) have significant therapeutic value, especially in the NSC/NPC transplantation therapy. However, the viability of the transplanted NSPCs remains low because of various factors, including oxidative stress.

objectiveThe current investigation explored the possible role of HspB5 in the protection of mouse NSPCs (

methodsThe recombinant human HspB5 was expressed in

resultsThe recombinant HspB5 was purified to its homogeneity and was characterized using various biophysical techniques. The externally added FITC-labeled HspB5 was found to be localized within the cytoplasm of

conclusionOur results clearly demonstrate that exogenously added recombinant human HspB5 enters the

Indexed as

cytoprotectionHspB5Neural stem/progenitor cellsparaquatαB-crystallin

Identifiers

PMID33489464
PMCPMC7811932
OpenAlexW3122743047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.